Tuesday, May 28, 2013

CANNABIS TAMPON WAITING ON F.D.A.

Cannabis Tampon Awaits F.D.A. Approval

A double sided Hemp-Indica tampon may be just what Women have been waiting for. Hempon (trade name) was designed by a Woman for Women. Very absorbent Hemp on the outer cylinder blunt shaped tampon, and analgesic laced Indica on the inner lining; Hempon is the future of feminine hygiene. Let's closely examine the two distinguishing properties of Hempon.
First, the Hemp lining showcases hemp fiber's multi-purpose use. Hemp is used world-wide in myriad instances of commercial productivity. From birdseed to rope and fabric to building materials- Hemp is one of the most useful commodities known to man. In Hempon, tightly woven and compressed Hemp (aged), offers heavy flow protection, unseen in similar female applications. Only Hempon utilizes triad strands of Hemp for the ultimate security in menstrual mobility and absorbency.
Next, the inner cylinder of Hempon is composed of Cannabis Indica. This intricate design creates close Tricomosome mixing of intra-Uterine lining blood cells. The highly oxygenated rich blood cells interact with Indica's analgesic properties, creating a pain buffer to menstrual cramps. It's easy to see why Women are already clamoring for this product. A female from the FDA, speaking only with the condition of anonymity states, "I just hope Male chauvinistic pig-ass red tape won't hinder this advancement for Women".
It is important that we all pay attention to changing proposals regarding Marijuana, as many contain allowances for Hemp cultivation. Free the Herb, and let Nature take it's course. We owe it to the Women of America!
SOURCE: Joyce at:  http://www.articlesbase.com/womens-health-articles/cannabis-tampon-awaits-fda-approval-3468533.html

 
 

Wednesday, May 15, 2013

PTSD

U.S.: Marijuana Cannabinoids Could Point The Way To First Effective Medication For PTSD - (Post Traumatic Stress Disorder)
  

In a first-of-its-kind study on the biochemical impact of psychological trauma, researchers have discovered a connection between the amount of cannabinoid receptors in the human brain and the chronic, disabling condition post-traumatic stress disorder (PTSD).

The findings, from New York University Langone Medical Center, appeared online Tuesday in the journal Molecular Psychiatry, reports Science Daily. They will also be presented this week at the annual meeting of the Society of Biological Psychiatry in San Francisco.

There are a number of treatments using psychotherapy and cognitive behavioral therapy for PTSD patients, but these methods aren't always available, reports Loren Grush at Fox News.

No pharmaceutical treatments have yet been developed to specifically target PTSD.

The NYU Langone Center researchers utilized brain imaging technology to highlight the connection between the number of cannabinoid receptors in the brain and PTSD. The cannabinoid receptors, known as CB1 receptors, are activated in the brain when a person uses marijuana, which can lead to impaired short-term memory and reduced anxiety.

CB1 receptors are part of the body's natural endocannabinoid system, a network of chemicals and signaling pathways in the body which plays a role in memory formation, appetite, pain tolerance and mood. Animal studies have shown that cannabis, along with natural neurotransmitters produced in the brain, can impair memory and reduce anxiety when the activate CB1 receptors in the brain.

There is a truth that must be heard!The new study is the first to show, through brain imaging, that people with PTSD have remarkably lower concentrations of at least one of these endocannabinoids -- anandamide -- than people without PTSD.
The findings pave the way for development of the first-ever medication designed specifically to treat PTSD, something that researchers say is desperately needed.

"The first line of treatment (for PTSD patients) is selective serotonin re-uptake inhibitors, which is a class of medication generally used with good effects in people with depression," said Dr. Alexander Neumeister, lead author of the study and director of the molecular imaging program in the departments of psychiatry and radiology at NYU School of Medicine.

"These medications do not really do the job for people with PTSD, so clinicians use anything else that is legally available on the market," Dr. Neumeister said. "They often use different classes of medications developed for things like depression, schizophrenia, or bipolar disorder, and overall there's a consensus that these do not work."

"There's not a single pharmacological treatment out there that has been developed specifically for PTSD," Dr. Neumeister said. "That's a problem.

"In fact, we know very well that people with PTSD who use marijuana -- a potent cannabinoid -- often experience more relief from their symptoms than they do from antidepressants and other psychiatric medications," Dr. Neumeister said. "Clearly, there's a very urgent need to develop novel evidence-based treatments for PTSD."

"About eight years ago, the first animal study was published showing that everybody has endogenous cannabinoids, or endocannabinoids, in the brain -- meaning this substance is in the brain of every person," Dr. Neumeister said. "Animal studies have suggested that increasing cannabinoids in the brain helps them to forget painful events and form new memories, so they start to learn to digest what they went through and get over it. We thought this may be relevant to PTSD."

The study divided 60 participants into three groups: those with PTSD; those with a history of trauma but no PTSD; and those with no history or either trauma or PTSD. Participants in all three groups received a radioactive tracer that illuminates CB1 receptors when exposed to PET scans.

Results showed that participants with PTSD, especially women, had more CB1 receptors in brain regions associated with fear and anxiety than volunteers without PTSD. The PTSD group also had less of the neurotransmitter anandamide, an endocannabinoid that binds to the CB1 receptor.

When anandamide levels are low, Dr. Neumeister explained, the brain compensates by increasing the number of CB1 receptors. "This helps the brain utilize the remaining endocannabinoids," he said.

"What is PTSD? It's an illness where people cannot forget what they have experienced," Dr. Neumeister said. "Our findings offer a possible explanation for this phenomenon."

Biological markers of PTSD -- such as these tests for CB1 receptors and anandamide levels -- could dramatically improve diagnosis and treatment for trauma victims, especially since current diagnostics for PTSD rely on subjective measures and patient recall, making it difficult to accurately diagnose the condition or distinguish it from depression and anxiety.

An estimated 20 percent of the 1.7 million men and women who have served in the wars in Iraq and Afghanistan have PTSD, but it is not limited to soldiers. Trauma from sexual and physical abuse, car accidents, natural disasters, and life-threatening medical diagnoses can lead to PTSD; it affects nearly 8 million Americans annually.

"We want to increase the concentration of these endocannabinoids," Dr. Neumeister said. "So we are currently working on the methods to do this, and we have developed a compound that is able to increase the concentration of endocannabinoids without attacking the receptors."

The thing is, we already have a safe, natural and organic way to increase the concentration of cannabinoids in the brain -- it's called smoking pot, and you don't have to pay a big pharmaceutical corporation to do so, at least yet, anyway.
But Neumeister said the compound he's investigating is "very safe" and does not come with the "added health problems" of marijuana use. Without detailing what "health problems" those would those be, exactly (studies have shown that not only does marijuana not harm the lungs or pulmonary system;
it actually appears to increase lung health.)

 

SOURCE: steveelliott's blog and Hemp.org

 


BRAVE MYKAYLA'S OIL

How to Make Cannabis Oil

Published on Jan 16, 2013 by Brandon Krenzler .  "This is a step by step video on how to make full-extract cannabis oil with food grade alcohol. This is the process used to produce Mykayla's oil as shown by Mike Mullins of Stony Girl Gardens. This is who taught us in person to make her oil. Thank you Mike and Jennifer for being willing to shoot a video to help our friends learn to make this oil for themselves. Thank you for the compassion you have shown Mykayla through all of this and your continued support and help in producing the majority of Mykayla's oil needs from the very beginning. For this we are thankful. Other videos to come soon."


!!! Dont Be Afraid To CURE Your Own Cancer - Cancer Doesn't Have To Be So Scary !!!

Read Brave Mykayla's Story Here
 

To find out more:

www.bravemykayla.com
www.facebook.com/bravemykayla
www.shop.bravemykayla.com
www.gro4me.com



Tuesday, May 14, 2013

EVERYTHING YOU NEED TO KNOW TO STOP CANCER

Everything you need to know to stop cancer
 
An exceptional interview covering
the who, what, when, where and most importantly HOW

Chris Wark who cured his own Colon Cancer
interviews documentary film maker Ian Jacklin


 
 
 

Thursday, May 9, 2013

BRAIN TUMOR


Full Doc - Hemp oil Cures Cancer: http://tinyurl.com/d9fexrh

Hemp Oil: One of Best Alternative Cancer Treatments:
http://tinyurl.com/d78y7rx

Everything you need to know to treat cancer:
http://tinyurl.com/cw8z4lw


****************

Origins of Cannabis International Foundation

 Dr. William Courtney